Bick C, Brien G, Fahlenkamp D, Koch R
Z Urol Nephrol. 1982 Nov;75(11):753-8.
The main indication for the application of Disalunil in the convalescent care of recidive calcium-lithiasis patients is renal hypercalciuria. Treatment with 50 mg Disalunil/d reduced the rate of recidivation by two thirds. Even during long-term application of this therapy over 3-7 years, side effects were slight and did not require any cessation of therapy.
双氯苯砜在复发性钙结石患者康复护理中的主要应用指征是肾性高钙尿症。每日50毫克双氯苯砜治疗可使复发率降低三分之二。即使在长达3至7年的长期应用该疗法过程中,副作用也很轻微,无需中断治疗。